Health IT, Startups

Blueprint Health grad ProofPilot raises $1.85M to make clinical trials cheaper and easier to run

Health IT company ProofPilot, which graduated from Blueprint Health’s accelerator earlier this year, has raised […]

Health IT company ProofPilot, which graduated from Blueprint Health’s accelerator earlier this year, has raised $1.85 million to help make clinical trial design and management for biotech and medical device companies run smoother. The information comes from an amended Form D filing with the U.S. Securities and Exchange Commission. Earlier this year the company had said it planned to raise a seed round to support sales.

The company zeroes in on one of the biggest costs of clinical trials — the time it takes to set them up and run. ProofPilot sees a few different ways to tackle the challenges that go along with setting trials up and managing them cheaper. It offers a set of tools to build surveys, identify tests and set measurement intervals, for example. To speed up recruitment, it provides a way to access connected health devices, collect and transmit data from those devices automatically, based on the company’s study design.

Matthew Amsden, the CEO and co-founder, has said a couple of the critical criteria in developing the software-as-a-service tool were that it had to be secure enough for regulators but easy enough for clinical research novices. The company’s primary sets of customers are medical device and biotech companies as well as marketing companies. It also works with outcomes agencies to explore consumer behavior. It charges a monthly subscription fee based on the complexity of studies.

Several companies are working on ways to improve clinical trial recruitment, which can be one of the most time-consuming parts of setting up trials. Some of the companies active in this area include Reg4All, TrialReach, Centerwatch and MProve Health (formerly Omniscience Mobile).

 

 

Shares0
Shares0